Suggested guidelines for the use of tacrolimus in cardiac transplant recipients

Journal of Heart and Lung Transplantation

Volumn 20, Issue 7, 2001, Pages 734-738

  Taylor, David O ^a   Barr, Mark L ^b   Meiser, Bruno M ^c   Pham, Si M ^d   Mentzer Jr, Robert M ^e   Gass, Alan L ^f  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYTOCHROME P450; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; GINGIVA HYPERPLASIA; GRAFT REJECTION; HEART TRANSPLANTATION; HIRSUTISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPOMAGNESEMIA; MONITORING; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE;

CLINICAL TRIALS; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INCOMPATIBILITY; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; PRACTICE GUIDELINES; TACROLIMUS;

EID: 0034935310     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00222-9     Document Type: Article

References (11)

1. A prospective trial of tacrolimus (FK506) in clinical heart transplantation; intermediate-term results
2. European multicenter tacrolimus (FK506) heart pilot study; one-year results-European Tacrolimus Multicenter Heart Study Group
3. Randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation; decreased hyperlipidemia and hypertension with tacrolimus
4. Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation; importance of mycophenolic acid therapeutic drug monitoring
5. Clinical trial of FK 506 immunosuppression in adult cardiac transplantation
6. Tacrolimus as a rescue immunosuppressant after heart and lung transplantation
7. Tacrolimus; a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation
8. Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection
9. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro finding
10. Effect of discontinuing cyclosporine on mycophenolic acid trough levels in kidney transplant recipients
11. Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation